Ranch Capital Advisors Inc. Astrazeneca PLC Transaction History

Ranch Capital Advisors Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$54.02 - $63.83 $66,282 - $78,319	-1,227 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$55.56 - $60.79 $8,889 - $9,726	-160 Reduced 11.54%	1,227 $74,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $500,130 - $621,599	-10,329 Reduced 88.16%	1,387 $83,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $177,698 - $205,129	-3,768 Reduced 24.33%	11,716 $582,000
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $3,930 - $4,699	81 Added 0.53%	15,484 $774,000
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $22,395 - $25,784	-422 Reduced 2.67%	15,403 $852,000
Q2 2020 Aug 12, 2020	BUY	$43.1 - $55.31 $682,057 - $875,280	15,825 New	15,825 $876,000

1,426

504M

10M

3.14M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $213B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ranch Capital Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Ranch Capital Advisors Inc. with notifications on news.